🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This long-term extension study is designed to monitor the long-term safety,...
Status
Completed
Location
Research Site
Start Date
2016-09-19
Trial ID
NCT02951026
Treatments Being Tested
The goal of this clinical trial is to determine whether telomere profiling ...
Status
Recruiting
Location
BEYOND GENOMiX Research and Coordination Center
Start Date
2025-01-01
Trial ID
NCT07404969
The present research project aims to compare the efficacy and safety of an ...
Status
Unknown
Location
Hospital de Clínicas de Porto Alegre
Start Date
2022-08-01
Trial ID
NCT05450614
Treatments Being Tested
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast can...
Status
Completed
Location
Sohag university
Start Date
2026-05-01
Trial ID
NCT07714382
Treatments Being Tested
This project is intended to acquire objective measurements of implementing ...
Status
Enrolling By Invitation
Location
University of Kansas medical Center
Start Date
2024-09-05
Trial ID
NCT06636045
Treatments Being Tested
This prospective observational diagnostic study aims to improve the accurac...
Status
Active Not Recruiting
Location
University Hospital Ghent (UZ Gent), Belgium
Start Date
2018-09-18
Trial ID
NCT07494630
Treatments Being Tested
The primary objectives of this study are to evaluate the safety, tolerabili...
Status
Terminated
Location
University of Colorado Denver
Start Date
2013-08-26
Trial ID
NCT01923311
Treatments Being Tested
The purpose of this study is to assess enzalutamide plus leuprolide in pati...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2014-12-17
Trial ID
NCT02319837
Treatments Being Tested
This is an exploratory study aimed at characterizing adherence to the Medit...
Status
Completed
Location
Centre Antoine lacassagne
Start Date
2023-09-04
Trial ID
NCT06058312
The CHIP-AML22 Master protocol has the overall aim of increasing the cure r...
Status
Recruiting
Location
Princess Máxima Center for pediatric oncology
Start Date
2024-02-06
Trial ID
NCT06262438